Myriad Genetics
MYGN
MYGN
187 hedge funds and large institutions have $1.49B invested in Myriad Genetics in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 59 increasing their positions, 66 reducing their positions, and 27 closing their positions.
Holders
187
Holders Change
-5
Holders Change %
-2.6%
% of All Funds
3.32%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
23
Increased
59
Reduced
66
Closed
27
Calls
$4.39M
Puts
$2.95M
Net Calls
+$1.44M
Net Calls Change
+$518K
Top Buyers
1 |
1
EARNEST Partners
Atlanta,
Georgia
|
$133M |
2 |
2
Morgan Stanley
New York
|
$44M |
3 |
GCM
3
Glenview Capital Management
New York
|
$72.8M |
4 |
4
Goldman Sachs
New York
|
$29.6M |
5 |
5
Bank of America
Charlotte,
North Carolina
|
$51.4M |